Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Metabolic & Weight Management · Miami, FL
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, investigated in metabolic and body-weight research models, and ReVia Life makes it available to investigators across Miami and South Florida's research community. Supplied strictly for laboratory and research use, each vial is backed by third-party COA testing. Research teams in Hialeah and Miami Beach can review documented purity data prior to any experimental design.
A triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Studies have investigated its multi-receptor pharmacology and effects on metabolic signaling pathways.
Retatrutide belongs to the investigational class of multi-receptor peptide agonists, and across Miami's research and longevity hub it draws attention from teams probing GLP-1, GIP, and glucagon receptor signaling in cell-based and preclinical models. As laboratories from Coral Gables to Hialeah and Miami Beach expand their metabolic-pathway work, this compound supports in-vitro structure-activity studies and receptor-binding assays for strictly non-clinical exploration.
Retatrutide is worked with by researchers throughout the Miami metro — including Miami Beach, Coral Gables, Hialeah, Doral, Kendall — and across Florida. South Florida's research and longevity hub. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Miami labs obtain Retatrutide?
Retatrutide is supplied through i2b Health, ReVia's research partner, to researchers in Miami and surrounding South Florida areas including Coral Gables, packaged for research-use-only delivery. It is provided exclusively for laboratory research and not for human consumption.
Does Retatrutide come with a COA?
Every batch is third-party tested and carries a Certificate of Analysis verifying identity and purity. Miami researchers can examine the COA before incorporating the compound into study work.
What is Retatrutide investigated for?
Retatrutide is investigated in research contexts as a GLP-1, GIP, and glucagon triple agonist relevant to metabolic and weight-management studies. All references are research-framed, with no clinical or therapeutic claims.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.